Dr. Flavia Marrero Nelson, MD

Dr. Nelson practices at UMiami Medicine - Neurology in Miami, Florida.

Dr. Nelson's NPI, 1891722518, was assigned on June 27, 2006. Dr. Nelson holds Florida license ME154456.

Dr. Nelson's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Dr. Nelson's primary practice is UMiami Medicine - Neurology in Miami, Florida. Dr. Nelson is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Nelson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nelson practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nelson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Nelson's licenses on file in 3 states: Florida, Minnesota and Texas.

CMS data shows 92 Medicare services from Dr. Nelson across 3 procedure codes in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $9,253 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Dr. Nelson in 2024. The largest group is under 65, with 19 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nelson's median patient age at 51, with 72% women.

In 2024, Dr. Nelson wrote 439 Medicare Part D claims for 55 patients. 92% of them were for generic drugs. CMS names the drug for 362 of them, across 14 drugs with 11 or more claims each, at $209,769 in total drug cost. In 2023, CMS named 154 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Nelson for performance year 2024, reported as part of a group. Dr. Nelson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nelson as offering telehealth.

Dmand AI links 31 papers to Dr. Nelson, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Multiple Sclerosis, Brain and Magnetic Resonance Imaging. Dr. Nelson has published most often in J Neuroimaging. Dr. Nelson's most frequent co-authors are Zafer Keser, MD, John Anil Lincoln, MD, PhD and Arash Kamali, MD.

Dmand AI links Dr. Nelson to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS and Multiple Sclerosis, Chronic Progressive. Sanofi sponsors the most, 2. Open Payments lists research payments to Dr. Nelson that name 2 trials.

CMS Open Payments shows 622 general payments to Dr. Nelson from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Sanofi and Genzyme US Companies paid the most, $241,813. It also lists 16 research payments totaling $11,687 from 2016 to 2018, naming 2 clinical trials.